LSIPR 50 2018: Richard Gonzalez
Richard Gonzalez was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Tony Coles
Tony Coles was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
Event preview: BioPharm America 2018
BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports.
LSIPR 50 2018: Kim Nasmyth
Kim Nasmyth was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Sandy Macrae
Sandy Macrae was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Manuel Salmeron-Sanchez and Matthew Dalby
Manuel Salmeron-Sanchez and Matthew Dalby were selected in the LSIPR 50 2018 publication for their influence on the life sciences industry. They featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Michel Sidibé
Michel Sidibé was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Naoko Munakata
Naoko Munakata was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Changyu Shen
Changyu Shen was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Donald Trump
Donald Trump was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
